Circulating levels of neutrophil-activating chemokines and neutrophil-derived enzymes—including CXCL1, CXCL8, NE, and MPO—are significantly elevated in MS and correlate with the formation of new inflammatory lesions (25–27). This evidence concerns the gene CXCL8 and myeloid sarcoma.